Bar-Meir M[au] - Search Results

Year	Number of Results
2000	1
2001	2
2004	3
2005	2
2006	1
2007	1
2008	1
2010	1
2011	2
2012	4
2013	2
2014	4
2015	6
2016	2
2017	4
2018	3
2019	5
2020	3
2021	3
2022	1

1

Effect of tolerance on the evolution of antibiotic resistance under drug combinations.

Liu J, Gefen O, Ronin I, Bar-Meir M, Balaban NQ. Liu J, et al. Among authors: bar meir m. Science. 2020 Jan 10;367(6474):200-204. doi: 10.1126/science.aay3041. Science. 2020. PMID: 31919223

2

The NICU flora: An effective technique to sample surfaces.

Sultan N, Shchors I, Assous MV, Bar-Meir M. Sultan N, et al. Among authors: bar meir m. PLoS One. 2021 Sep 23;16(9):e0257821. doi: 10.1371/journal.pone.0257821. eCollection 2021. PLoS One. 2021. PMID: 34555096 Free PMC article.

3

Characterizing the differences between multisystem inflammatory syndrome in children and Kawasaki disease.

Bar-Meir M, Guri A, Godfrey ME, Shack AR, Hashkes PJ, Goldzweig O, Megged O. Bar-Meir M, et al. Sci Rep. 2021 Jul 5;11(1):13840. doi: 10.1038/s41598-021-93389-0. Sci Rep. 2021. PMID: 34226639 Free PMC article.

4

Management of brain abscesses in children.

Yogev R, Bar-Meir M. Yogev R, et al. Among authors: bar meir m. Pediatr Infect Dis J. 2004 Feb;23(2):157-9. doi: 10.1097/01.inf.0000110272.67271.a2. Pediatr Infect Dis J. 2004. PMID: 14872183 Review. No abstract available.

5

Clinical significance of microbial infection and adaptation in cystic fibrosis.

Hauser AR, Jain M, Bar-Meir M, McColley SA. Hauser AR, et al. Among authors: bar meir m. Clin Microbiol Rev. 2011 Jan;24(1):29-70. doi: 10.1128/CMR.00036-10. Clin Microbiol Rev. 2011. PMID: 21233507 Free PMC article. Review.

6

Kawasaki disease in Israel.

Bar-Meir M, Haklai Z, Dor M. Bar-Meir M, et al. Pediatr Infect Dis J. 2011 Jul;30(7):589-92. doi: 10.1097/INF.0b013e31820e3849. Pediatr Infect Dis J. 2011. PMID: 21343843

7

Identifying factors affecting latent tuberculosis treatment acceptance among healthcare workers: a retrospective analysis in a tertiary care centre.

Bar-Meir M, Pariente G, Romem A, Wiener-Well Y. Bar-Meir M, et al. BMJ Open. 2021 Sep 7;11(9):e047444. doi: 10.1136/bmjopen-2020-047444. BMJ Open. 2021. PMID: 34493512 Free PMC article.

8

Gradenigo's syndrome: is fusobacterium different? Two cases and review of the literature.

Heshin-Bekenstein M, Megged O, Peleg U, Shahroor-Karni S, Bass R, Benifla M, Bar-Meir M. Heshin-Bekenstein M, et al. Among authors: bar meir m. Int J Pediatr Otorhinolaryngol. 2014 Jan;78(1):166-9. doi: 10.1016/j.ijporl.2013.11.004. Epub 2013 Nov 20. Int J Pediatr Otorhinolaryngol. 2014. PMID: 24315216 Review.

9

The utility of MALDI-TOF MS for outbreak investigation in the neonatal intensive care unit.

Bar-Meir M, Berliner E, Kashat L, Zeevi DA, Assous MV. Bar-Meir M, et al. Eur J Pediatr. 2020 Dec;179(12):1843-1849. doi: 10.1007/s00431-020-03696-3. Epub 2020 Jun 10. Eur J Pediatr. 2020. PMID: 32524198 Free PMC article.

10

Prediction of Resistance to Intravenous Immunoglobulin in Children With Kawasaki Disease.

Bar-Meir M, Kalisky I, Schwartz A, Somekh E, Tasher D; Israeli Kawasaki Group. Bar-Meir M, et al. J Pediatric Infect Dis Soc. 2018 Feb 19;7(1):25-29. doi: 10.1093/jpids/piw075. J Pediatric Infect Dis Soc. 2018. PMID: 28062554

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results